BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3299121)

  • 1. The islets of Langerhans in uremic patients receiving chronic hemodialysis.
    Suda K; Ariwa R
    Nephron; 1987; 46(2):134-6. PubMed ID: 3299121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal Langerhans cells in uremic patients on hemodialysis or continuous ambulatory peritoneal dialysis.
    Mettang T; Fritz P; Weber J; Machleidt C; Hübel E; Kiefer T; Kuhlmann U
    Nephron; 1993; 65(2):278-83. PubMed ID: 8247193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose, insulin and glucagon response to intravenous glucose load in patients on chronic hemodialysis.
    Shasha SM; Nusem D; Kanter Y; Weiner F
    Isr J Med Sci; 1988 Jan; 24(1):15-9. PubMed ID: 3279011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
    Alvestrand A; Mujagic M; Wajngot A; Efendic S
    Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin.
    DeFronzo RA; Tobin JD; Rowe JW; Andres R
    J Clin Invest; 1978 Aug; 62(2):425-35. PubMed ID: 353075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic study of islets of Langerhans in patients after gastrectomy.
    Suda K; Takei K; Suzuki F; Kamano T; Yamane T
    J Clin Gastroenterol; 1997 Oct; 25(3):546-9. PubMed ID: 9412976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is glucose intolerance harmful for the uremic patient?
    DeFronzo RA; Smith JD
    Kidney Int Suppl; 1985 Dec; 17():S88-97. PubMed ID: 3912590
    [No Abstract]   [Full Text] [Related]  

  • 8. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of nutrition in dialysis patients and chronic uremic patients].
    Liu H; Duan X; Li G
    Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):727-30. PubMed ID: 10451942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinicopathologic study on islets of Langerhans in cases of chronic dialysis].
    Suda K; Ariwa R
    Rinsho Byori; 1986 Mar; 34(3):325-7. PubMed ID: 3520049
    [No Abstract]   [Full Text] [Related]  

  • 12. Destructive spondyloarthropathy with beta 2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis.
    Morinière P; Marie A; el Esper N; Fardellone P; Deramond H; Remond A; Sebert JL; Fournier A
    Nephron; 1991; 59(4):654-7. PubMed ID: 1766508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of the metabolism of fibrinogen-I 125 in cases of chronic glomerulonephritis and pyelonephritis and in uremic patients treated by periodical hemodialysis].
    Huber W; Previato G; Bertoli M; Cancarini GC; Toigo G; Gasparotto ML; Romagnoli GF
    G Clin Med; 1975; 56(11-12):431-44. PubMed ID: 1233337
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of the artificial pancreas in uremic diabetic patients.
    Slama G; Klein JC; Delage A; Rottembourg J; Marouani A; Jacobs C
    Horm Metab Res Suppl; 1979; (8):178-83. PubMed ID: 395076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray microanalysis of the fingernails of uremic patients treated by hemodialysis.
    Zevin D; Weinstein T; Levi J; Djaldetti M
    Clin Nephrol; 1991 Dec; 36(6):302-4. PubMed ID: 1769143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment.
    de Koning EJ; Fleming KA; Gray DW; Clark A
    J Pathol; 1995 Feb; 175(2):253-8. PubMed ID: 7738722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
    Salvati F; Liani M
    Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher islet amyloid load in men than in women with type 2 diabetes mellitus.
    Zhao HL; Sui Y; Guan J; He L; Lai FM; Zhong DR; Yang D; Baum L; Tong PC; Tomlinson B; Chan JC
    Pancreas; 2008 Oct; 37(3):e68-73. PubMed ID: 18815541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant increase of IQ-type heterocyclic amines, dietary carcinogens in the plasma of patients with uremia just before induction of hemodialysis treatment.
    Yanagisawa H; Wada O
    Nephron; 1989; 52(1):6-10. PubMed ID: 2710268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.